UCLA Hematology Oncology-Alhambra — Alhambra, California

UCLA Hematology Oncology-Alhambra is a clinical research site located in Alhambra, California, United States 91801.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

UCLA Hematology Oncology-Alhambra has participated in 8 clinical trials with 3 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer, Advanced Solid Tumors, HER2-positive Breast Cancer.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Alhambra

Browse all research sites in California · View every site in Alhambra

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology Oncology-Alhambra?

UCLA Hematology Oncology-Alhambra has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology Oncology-Alhambra conducted?

UCLA Hematology Oncology-Alhambra has 8 clinical trials on record, with 3 currently active. Their work covers Non-Small Cell Lung Cancer, Advanced Solid Tumors, HER2-positive Breast Cancer.

Is UCLA Hematology Oncology-Alhambra accredited by Crixeo Clinical Trials?

UCLA Hematology Oncology-Alhambra has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematology Oncology-Alhambra?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.